HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- oxo- 1- (5- (2- pyridyl)- 2- yl)- 7- phenylheptane

reversible inhibitor of fatty acid amide hydrolase (FAAH) that promotes analgesia; structure in first source

Also Known As:

OL-135

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 1-oxo-1-(5-(2-pyridyl)-2-yl)-7-phenylheptane: 2

Experts

1.	Bilsky, Edward J: 1 article (01/2016)
2.	Bind, Rebecca: 1 article (01/2016)
3.	Boger, Dale L: 1 article (01/2016)
4.	Burman, Michael A: 1 article (01/2016)
5.	Kerney, Kristen: 1 article (01/2016)
6.	Szolusha, Kerribeth: 1 article (01/2016)
7.	Ahn, Kyunghye: 1 article (05/2007)
8.	Cravatt, Benjamin F: 1 article (05/2007)
9.	Lichtman, Aron H: 1 article (05/2007)
10.	Martin, Billy R: 1 article (05/2007)

Related Diseases

1.	Wounds and Injuries (Trauma) 01/01/2016 - "The current experiments examine the effects of low (5.6mg/kg) or moderate (10.0mg/kg) doses of OL-135, a FAAH inhibitor, on the acquisition and consolidation of classical fear conditioning, a common model of trauma-induced anxiety. "
2.	Hypothermia 05/01/2007 - "The doses of URB597 and OL-135 selected were based on their ability to augment the pharmacological effects (i.e., analgesia, catalepsy, and hypothermia) of exogenously administered anandamide. "
3.	Catalepsy 05/01/2007 - "The doses of URB597 and OL-135 selected were based on their ability to augment the pharmacological effects (i.e., analgesia, catalepsy, and hypothermia) of exogenously administered anandamide. "

Related Drugs and Biologics

1.	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)
2.	anandamide (arachidonylethanolamide)

Related Therapies and Procedures

1.	Analgesia